News

news

News


Alimentiv’s model attracts eyes across the medical community and beyond. Here are the latest stories people are telling about us, our mission and our unique Health Trust.

Alimentiv Launch Announced

Alimentiv, Inc. formerly Robarts Clinical Trials, announced today a major rebranding to reflect the company’s continued growth as a specialized global gastrointestinal (GI) contract research organization (CRO).

read more

Alimentiv COVID-19 Announcement

Alimentiv’s Response to the COVID-19 pandemic and how we are still working to provide safe, quality service to our partners, sponsors, vendors and investigators.

read more

Optimal Biopsy Location for Biomarker Analyses

The appropriate location for biopsy sampling is a common question in gastrointestinal diseases such as Crohn’s disease (CD) and ulcerative colitis (UC). Standardization of biopsy procurement is essential during drug development to define response to therapy.

read more

Facilitating Drug Development in Under-served Patient Populations

Development of a Radiological Index for Peri-anal Crohn’s Disease

read more